Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BACKGROUND: Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were reported to be common...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Yang, Yuchong, Huang, Xuanzhang, Zhou, Likun, Deng, Ting, Ning, Tao, Liu, Rui, Zhang, Le, Bai, Ming, Zhang, Haiyang, Li, Hongli, Ba, Yi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6544972/
https://ncbi.nlm.nih.gov/pubmed/31151431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5755-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky